Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Especialistas en Retina Médica y Quirúrgica (ERMQ) is a specialized medical and research group based in Spain, dedicated to the diagnosis, treatment, and clinical investigation of vitreoretinal diseases. The organization operates as a high-volume clinical research site, collaborating with global pharmaceutical companies to conduct Phase 2, 3, and 4 clinical trials. Their expertise covers a broad spectrum of ophthalmic conditions, including neovascular age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. ERMQ integrates advanced surgical capabilities with a robust research infrastructure, contributing significantly to the development of new pharmacological and gene therapy treatments in ophthalmology. The group is recognized for its clinical excellence and its role as a key investigative center in international multicenter studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Especialistas en Retina Médica y Quirúrgica Grupo de Investigación.